| CAR T cell therapy for solid tumors: bright future or dark reality? J Wagner, E Wickman, C DeRenzo, S Gottschalk Molecular therapy 28 (11), 2320-2339, 2020 | 269 | 2020 |
| Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity B Prinzing, CC Zebley, CT Petersen, Y Fan, AA Anido, Z Yi, P Nguyen, ... Science translational medicine 13 (620), eabh0272, 2021 | 175 | 2021 |
| Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma M Hegde, SK Joseph, F Pashankar, C DeRenzo, K Sanber, S Navai, ... Nature communications 11 (1), 3549, 2020 | 127 | 2020 |
| cBAF complex components and MYC cooperate early in CD8+ T cell fate A Guo, H Huang, Z Zhu, MJ Chen, H Shi, S Yuan, P Sharma, JP Connelly, ... Nature 607 (7917), 135-141, 2022 | 96 | 2022 |
| Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery D Haydar, H Houke, J Chiang, Z Yi, Z Odé, K Caldwell, X Zhu, KS Mercer, ... Neuro-oncology 23 (6), 999-1011, 2021 | 80 | 2021 |
| Genetic modification strategies to enhance CAR T cell persistence for patients with solid tumors C DeRenzo, S Gottschalk Frontiers in Immunology 10, 218, 2019 | 55 | 2019 |
| Abstract LB-147: Administration of HER2-CAR T cells after lymphodepletion safely improves T cell expansion and induces clinical responses in patients with advanced sarcomas SA Navai, C Derenzo, S Joseph, K Sanber, T Byrd, H Zhang, M Mata, ... Cancer Research 79 (13_Supplement), LB-147-LB-147, 2019 | 50 | 2019 |
| Route of 41BB/41BBL costimulation determines effector function of B7-H3-CAR. CD28ζ T cells P Nguyen, E Okeke, M Clay, D Haydar, J Justice, C O’Reilly, ... Molecular Therapy-Oncolytics 18, 202-214, 2020 | 48 | 2020 |
| Autoshaping of ethanol drinking: an animal model of binge drinking A Tomie, J Di Poce, CC Derenzo, LA Pohorecky Alcohol and Alcoholism 37 (2), 138-146, 2002 | 47 | 2002 |
| Expansion of HER2-CAR T cells after lymphodepletion and clinical responses in patients with advanced sarcoma. M Hegde, CC DeRenzo, H Zhang, M Mata, C Gerken, A Shree, Z Yi, ... Journal of Clinical Oncology 35 (15_suppl), 10508-10508, 2017 | 45 | 2017 |
| The landscape of CAR T cells beyond acute lymphoblastic leukemia for pediatric solid tumors C DeRenzo, G Krenciute, S Gottschalk American Society of Clinical Oncology Educational Book 38, 830-837, 2018 | 31 | 2018 |
| P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and-independent mechanisms SY Lin, SC Dolfi, S Amiri, J Li, T Budak-Alpdogan, KC Lee, C Derenzo, ... International Journal of Oncology 43 (6), 1817-1823, 2013 | 30 | 2013 |
| Genetically modified T cells to target glioblastoma S Krebs, TG Rodríguez-Cruz, C DeRenzo, S Gottschalk Frontiers in oncology 3, 322, 2013 | 28 | 2013 |
| A novel orthotopic implantation technique for osteosarcoma produces spontaneous metastases and illustrates dose-dependent efficacy of B7-H3-CAR T cells LJ Talbot, A Chabot, A Funk, P Nguyen, J Wagner, A Ross, H Tillman, ... Frontiers in Immunology 12, 691741, 2021 | 23 | 2021 |
| Genetically modified T-cell therapy for osteosarcoma C DeRenzo, S Gottschalk Current Advances in Osteosarcoma, 323-340, 2014 | 22 | 2014 |
| Nonoperative management of abdominoscrotal hydroceles in an infant CC De Renzo, JG Barone Urology 68 (2), 428. e9-428. e11, 2006 | 22 | 2006 |
| A costimulatory CAR improves TCR-based cancer immunotherapy B Omer, MG Cardenas, T Pfeiffer, R Daum, M Huynh, S Sharma, ... Cancer immunology research 10 (4), 512-524, 2022 | 19 | 2022 |
| Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma C DeRenzo, C Lam, C Rodriguez‐Galindo, L Rapkin, S Gottschalk, ... Pediatric blood & cancer 66 (1), e27469, 2019 | 15 | 2019 |
| Engineering oncolytic vaccinia virus to redirect macrophages to tumor cells F Cao, P Nguyen, B Hong, C DeRenzo, NC Rainusso, T Rodriguez Cruz, ... Advances in cell and gene therapy 4 (2), e99, 2021 | 11 | 2021 |
| Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma. Nat Commun. 2020; 11 (1): 3549 M Hegde, SK Joseph, F Pashankar, C DeRenzo, K Sanber, S Navai, ... DOI: https://doi. org/10.1038/s41467-020-17175-8, 3549, 0 | 11 | |
